Control of separate pathogenic autoantibody responses marks MHC gene contributions to murine lupus
- PMID: 10393954
- PMCID: PMC22194
- DOI: 10.1073/pnas.96.14.8098
Control of separate pathogenic autoantibody responses marks MHC gene contributions to murine lupus
Abstract
Previous studies have suggested that MHC and non-MHC genes contribute to the development of autoimmune disease in F1 hybrids of New Zealand black (NZB) and white (NZW) mice. We conducted a genome-wide screen of 148 female (NZB x NZW)F1 x NZB backcross mice to map dominant NZW genetic loci linked with lupus disease traits. In this backcross analysis, inheritance of the NZW MHC (H2(d/z) vs. H2(d/d)) was strongly linked with the development of lupus nephritis (P approximately 1 x 10(-16)), increasing the risk of disease by over 30-fold. H2(d/z) was also linked with elevated serum levels of IgG autoantibodies to single-stranded DNA, double-stranded DNA, histones, and chromatin but not with anti-gp70 autoantibodies, measured as circulating gp70-anti-gp70 immune complexes. Non-MHC contributions from NZW seemed weak in comparison to MHC, although NZW loci on chromosomes 7 and 16 were noted to be suggestively linked with autoantibody production. Strikingly, H2(d/z) (compared with H2(d/d)) enhanced antinuclear antibodies in a coordinate fashion but did not affect anti-gp70 production in the current backcross. However, the opposite influence was noted for H2(d/z) (compared with H2(z/z)) when (NZB x NZW)F1 x NZW backcross mice were analyzed. These results suggest that H2(z) and H2(d) haplotypes differentially regulate two different sets of nephritogenic autoantibody responses. This study confirms a critical role for H2(z) compared with other dominant NZW loci in (NZB x NZW)F1 mice and provides an explanation as to why H2(d/z) heterozygosity is required for full expression of disease in this model.
Figures



References
-
- Howie J B, Helyer B J. Adv Immunol. 1968;9:215–266. - PubMed
-
- Theofilopoulos A N. In: Systemic Lupus Erythematosus. Lahita R G, editor. New York: Churchill Livingstone; 1992. pp. 121–194.
-
- Kotzin B L. Cell. 1996;85:303–306. - PubMed
-
- Madaio M P, Carlson J, Cataldo J, Ucci A, Migliorini P, Pankewycz O. J Immunol. 1987;138:2883–2889. - PubMed
-
- Raz E, Brezis M, Rosenmann E, Eilat D. J Immunol. 1989;142:3076–3082. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases
Research Materials